Effects of Clazakizumab on Anemia and Iron Metabolism in Patients with Kidney Failure.

Neuen, Brendon L; Catanese, Benjamin; Chang, Annamarie; Heise, Mark; Tricoci, Pierluigi; Eckardt, Kai-Uwe; Felker, G Michael; Mahaffey, Kenneth W; Wolf, Myles; Chertow, Glenn M; on behalf of the POSIBIL ESKD Investigators; Jadoul, Michel

doi:10.1681/ASN.0000000654

Effects of Clazakizumab on Anemia and Iron Metabolism in Patients with Kidney Failure.

Neuen, Brendon L

;

Catanese, Benjamin

;

Chang, Annamarie

;

Heise, Mark

;

Jadoul, Michel

;et.al.

(2025) Journal of the American Society of Nephrology : JASN — Vol. 36, p. 923-925 (2025)

Files

Neuenetaleffects_of_clazakizumab_on_anemia_and_iron556.pdf

Open Access
Adobe PDF
257.81 KB

Download

Details

Authors

Neuen, Brendon L
Author
Catanese, Benjamin
Author
Chang, Annamarie
Author
Heise, Mark
Author
Jadoul, MichelUCLouvain
Author

Affiliations

UCLouvainSSS/IREC/NEFR - Pôle de Néphrologie
UCLouvain(SLuc) Service de néphrologie

Citations

APA
Chicago
FWB

Neuen, B. L., Catanese, B., Chang, A., Heise, M., Tricoci, P., Eckardt, K.-U., Felker, G. M., Mahaffey, K. W., Wolf, M., Chertow, G. M., & Jadoul, M. (2025). Effects of Clazakizumab on Anemia and Iron Metabolism in Patients with Kidney Failure. Journal of the American Society of Nephrology : JASN, 36, 923-925. https://doi.org/10.1681/ASN.0000000654 (Original work published 2025)